Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Induction of intercellular interaction and cell fusion by cell-penetrating peptide-conjugated lipids.

Sato Y., Chung UI., Teramura Y.

Animal Study on Face & Skin, published in J Mater Chem B (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Mater Chem B (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40891702
DOI
10.1039/d5tb01318f
Citations
1

Abstract (original English)

Cell fusion is widely used in biomedical applications. However, conventional cell fusion methods, including polyethylene glycol (PEG)-based methods, often exhibit low efficiency. In this study, we investigated an alternative strategy to induce cell fusion with higher efficiency using transactivator of transcription peptide-conjugated PEG-lipids (Tat-PEG-lipids) with lauroyl chains (C12). We demonstrated the homogeneous cell fusion of human acute lymphoblastic leukemia T (CCRF-CEM) cells and heterogeneous cell fusion of CCRF-CEM cells with murine myeloma P3U1 cells, and human adipose-derived stem cells (hADSCs) with P3U1 cells. We first evaluated the cell surface modification of Tat-PEG-lipid (C12) by confocal laser scanning microscopy and flow cytometry, studying its concentration-dependent incorporation into the cell membrane and the corresponding changes in the surface charge. Kinetic analysis revealed that the half-life of Tat-PEG-lipid (C12) on the cell membrane was approximately 9 h. In addition, the critical surface density of Tat-PEG-lipid (C12) for inducing cell fusion was approximately 5.1 × 10 4 molecules per cell. Reaction temperature was an important factor; cell fusion occurred at 37 °C but not at 4 °C, indicating that membrane fluidity was required for lipid exchange between adjacent attached cells. We found that Tat-PEG-lipid-mediated cell fusion can occur in var

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansCell-Penetrating PeptidesAnimalsMicePolyethylene GlycolsCell FusionLipidsCell CommunicationCell Line, Tumor

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research